Precision BioSciences, Inc. (DTIL)

NASDAQ: DTIL · Real-Time Price · USD

6.97

+0.02 (0.29%)

At close: Nov 3, 2026, 4:00 PM EST

6.75

-0.22 (-3.16%)

After-hours: Nov 3, 2026, 4:10 PM EST

Precision BioSciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	-	110.82	85.9	116.68	189.58	143.66
Short-Term Investments	-	4.76	0.41	-	-	-
Cash & Short-Term Investments	87.55	115.59	86.31	116.68	189.58	143.66
Cash Growth	95.12%	33.91%	-26.02%	-38.45%	31.96%	59.98%
Accounts Receivable	-	-	1.7	0.9	0.72	0.49
Receivables	-	-	1.7	12.8	0.72	0.49
Prepaid Expenses	-	3.11	6.44	5.98	6.03	17.43
Other Current Assets	-	0.05	0.54	0.91	2.78	0.17
Total Current Assets	-	118.74	94.99	136.36	199.11	161.75
Property, Plant & Equipment	-	7.23	10.18	14.6	13.78	29.33
Long-Term Investments	-	0.74	3.21	3.21	4.75	6.84
Other Intangible Assets	-	1.17	0.62	0.4	0.73	2.05
Other Long-Term Assets	-	26.54	22.79	0.23	12.57	4.64
Total Assets	-	154.42	136.39	159.78	238.17	211.5

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	-	0.3	1.31	2.97	0.65	1.14
Accrued Expenses	-	6.46	7.2	6.54	6.93	10.79
Short-Term Debt	-	-	-	22.41	-	-
Current Portion of Leases	-	1.51	1.32	1.13	1.68	1.82
Current Unearned Revenue	-	-	2.96	12.04	46.19	21.24
Other Current Liabilities	-	0.65	2.19	4.9	4.21	0.98
Total Current Liabilities	-	8.91	14.98	49.99	59.66	35.98
Long-Term Debt	-	22.4	22.32	-	22.22	2.48
Long-Term Leases	-	4.9	6.4	7.72	1.06	4.81
Long-Term Unearned Revenue	-	10	33.3	83.08	92.87	77.02
Other Long-Term Liabilities	-	15.95	2.99	0.13	1.92	0.04
Total Liabilities	-	62.17	80	140.92	177.74	120.33

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	-	0	0	0	0	-
Additional Paid-In Capital	-	621.39	539.81	509.44	489.7	408.8
Retained Earnings	-	-528.19	-482.46	-489.63	-428.31	-316.68
Treasury Stock	-	-0.95	-0.95	-0.95	-0.95	-0.95
Total Common Equity	45.29	92.25	56.39	18.86	60.43	91.17
Shareholders' Equity	45.29	92.25	56.39	18.86	60.43	91.17
Total Liabilities & Equity	-	154.42	136.39	159.78	238.17	211.5

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	28.1	28.81	30.05	31.27	24.96	9.11
Net Cash (Debt)	59.45	86.78	56.27	85.41	164.62	134.55
Net Cash Growth	277.64%	54.22%	-34.12%	-48.12%	22.35%	69.72%
Net Cash Per Share	2.45	6.77	8.17	22.23	56.19	68.78
Filing Date Shares Outstanding	27.43	24.73	10.48	6.92	3.71	2.03
Total Common Shares Outstanding	27.43	24.09	8.2	4.16	3.7	2.03
Working Capital	-	109.83	80.01	86.37	139.44	125.77
Book Value Per Share	1.71	3.83	6.87	4.53	16.34	44.91
Tangible Book Value	44.2	91.08	55.77	18.46	59.7	89.12
Tangible Book Value Per Share	1.67	3.78	6.80	4.43	16.14	43.90
Machinery	-	17.62	18.7	19.38	20.78	22.93
Construction In Progress	-	-	0.01	0.07	0.52	3.04
Leasehold Improvements	-	12.06	12.03	11.95	11.95	22.78

SEC Filings: 10-K · 10-Q